Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

"Angitia doses first subject in Phase II trial of AGA2118 for treating osteoporosis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

On November 1, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as 'Chipscreen Biosciences') and its wholly-owned subsidiary Chengdu Chipscreen Pharmaceutical Ltd., received the ...

The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of ...

The phase 2 study included 47 patients with MCI or early AD ... Craft told attendees that longer and larger trials are ...

A Phase II clinical trial of RECCE 327 Topical Gel is nearing completion with data so far showing a strong therapeutic response.

The clinical research industry is a booming one, with a global value standing at over US$480bil last year, and it is ...

PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...

Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...